Received: 11 September 2019
Accepted: 21 April 2020
First Online: 1 May 2020
Ethics approval and consent to participate
: An ethics statement appears at the end of the methods section. The study’s reference number with Tel Aviv Sourasky Medical Center’s Institutional Review Board is 0485–13-TLV.
: Yehuda Carmeli reports grants and/or personal fees from MSD, AstraZeneca, DaVoltera, Intercell AG, Allecra Therapeutics, BioMerieux SA, Rempex Pharmaceuticals, Nariva, Achoagen, Roche, Pfizer, and Shionogi. The other authors have no conflict to declare.